The association between social anhedonia, withdrawal and psychotic experiences in general and high-risk populations

Schizophrenia Research

Volumn 138, Issue 2-3, 2012, Pages 290-294

  Velthorst, Eva ^a   Meijer, Carin ^a   Kahn, René S ^b   Linszen, Don H ^a   vanOs, Jim ^c,d   Wiersm, Durk ^e   Bruggeman, Richard ^e   Cahn, Wiepke ^b   de Haan, Lieuwe ^a   Krabbendam, Lydia ^c   Myin Germeys, Inez ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Psychosis; Psychotic experiences; Schizophrenia; Social anhedonia; Social withdrawal

Indexed keywords

ADULT; ANHEDONIA; ARTICLE; CLINICAL FEATURE; COMMUNITY ASSESSMENT OF PSYCHIC EXPERIENCES; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTRESS SYNDROME; FEMALE; GENETIC RISK AND OUTCOME IN PSYCHOSIS; HIGH RISK POPULATION; HUMAN; INTROVERSION; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; PSYCHOSOCIAL WITHDRAWAL; SOCIAL ISOLATION; SOCIAL PSYCHOLOGY; STRUCTURED INTERVIEW FOR SCIZOTYPY REVISED;

ADULT; ANHEDONIA; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DELUSIONS; FEMALE; HALLUCINATIONS; HUMANS; MALE; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SIBLINGS;

EID: 84862146897     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.03.022     Document Type: Article

References (38)

1. Andreassen N.C. Negative symptoms in schizophrenia. Definition and reliability. Arch. Gen. Psychiatry 1982, 39(7):784-788.
2. Blanchard J.J., Collins L.M., Aghevli M., Leung W.W., Cohen A.S. Social anhedonia and schizotypy in a community sample: the Maryland longitudinal study of schizotypy. Schizophr. Bull. 2011, 37(3):587-602.
3. Bleuler E. Dementia praecox or the group of schizophrenias (J. Zinkin, Trans.) 1950/1911, International Universities Press, New York.
4. Blyler C.R., Gold J.M., Iannone V.N., Buchanan R.W. Short form of the WAIS-III for use with patients with schizophrenia. Schizophr. Res. 2000, 46(2-3):209-215.
5. Brenner K., Schmitz N., Pawliuk N., Fathalli F., Joober R., Ciampi A., King S. Validation of the English and French versions of the Community Assessment of Psychic Experiences (CAPE) with a Montreal community sample. Schizophr. Res. 2007, 95(1-3):86-95.
6. Chapman L.J., Chapman J.P., Daut R.L. Schizophrenic inability to disattend from strong aspects of meaning. J. Abnorm. Psychol. 1976, 85(1):35-40.
7. Collins L.M., Blanchard J.J., Biondo K.M. Behavioral signs of schizoidia and schizotypy in social anhedonics. Schizophr. Res. 2005, 78(2-3):309-322.
8. Fett, A.K.J., Maat, A., GROUP investigators, in press. Social cognitive impairments and psychotic symptoms: what is the nature of their association? Schizophr. Bull.
9. Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis. Arch. Gen. Psychiatry 2011, 68(2):138-147. Genetic Risk and Outcome in Psychosis (GROUP) investigators.
10. Hanssen M., Peeters F., Krabbendam L., Radstake S., Verdoux H., Van Os J. How psychotic are individuals with non-psychotic disorders?. Soc. Psychiatry Psychiatr. Epidemiol. 2003, 38(3):149-154.
11. Hanssen M., Krabbendam L., Vollema M., Delespaul P., van Os J. Evidence for instrument and family specific variation of subclinical psychosis dimensions in the general population. J. Abnorm. Psychol. 2006, 115(1):5-14.
12. Hommes J., Krabbendam L., Versmissen D., Kircher T., van Os J., van Winkel R. Self-monitoring as a familial vulnerability marker for psychosis: an analysis of patients, unaffected siblings and healthy controls. Psychol. Med. 2012, 42:235-245.
13. Horan W.P., Brown S.A., Blanchard J.J. Social anhedonia and schizotypy: the contribution of individual differences in affective traits, stress, and coping. Psychiatry Res. 2007, 149(1-3):147-156.
14. Juckel G., Sass L., Heinz A. Anhedonia, self-experience in schizophrenia, and implications for treatment. Pharmacopsychiatry 2003, 36:176-180.
15. Katsanis J., Lacono W.G., Beiser M. Anhedonia and perceptual aberration in first-episode psychotic patients and their relatives. J. Abnorm. Psychol. 1990, 99(2):202-206.
16. Kayton L., Koh S.D. Hypohedonia in schizophrenia. J. Nerv. Ment. Dis. 1975, 161(6):412-420.
17. Kendler K.S., Lieberman J.A., Walsh D. The Structured Interview for Schizotypy (SIS): a preliminary report. Schizophr. Bull. 1989, 15(4):559-571.
18. Kendler K.S., Thacker L., Walsh D. Self-report measures of schizotypy as indices of familial vulnerability to schizophrenia. Schizophr. Bull. 1996, 22(3):511-520.
19. Konings M., Bak M., Hanssen M., van Os J., Krabbendam L. Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatr. Scand. 2006, 114(1):55-61.
20. Korver, N., Quee, P.J., Boos, H.B.M., Simons, C., G.R.O.U.P, in press. Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene-environment interaction: Objectives, Sample Characteristics, Recruitment and Assessment Methods. Int. J. Methods Psychiatr. Res.
21. Kraepelin E., Gosline H.I. The signs of mental disorder. Alienist Neurol. 1919, 40:85-108.
22. Kwapil T.R. Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders. J. Abnorm. Psychol. 1998, 107(4):558-565.
23. Laurent A., Biloa-Tang M., Bougerol T., Duly D., Anchisi A.M., Bosson J.L., Pellat J., d'Amato T., Dalery J. Executive/attentional performance and measures of schizotypy in patients with schizophrenia and in their nonpsychotic first-degree relatives. Schizophr. Res. 2000, 46(2-3):269-283.
24. Meehl P.E. Schizotaxia, schizotypy, and schizophrenia. Am. Psychol. 1962, 17:827-838.
25. Meijer J., Simons C.J.P., Quee P.J., Verweij K., GROUP Investigators Cognitive alterations in patients with non-affective psychotic disorder and their unaffected siblings and parents. Acta Psychiatr. Scand. 2012, 125(1):66-76.
26. Miller T.J., McGlashan T.H., Rosen J.L., Cadenhead K., Cannon T., Ventura J., McFarlane W., Perkins D.O., Pearlson G.D., Woods S.W. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr. Bull. 2003, 29(4):703-715.
27. Rado S. Dynamics and classification of disordered behaviour. Am. J. Psychiatry 1953, 110(406):416.
28. Rey G., Jouvent R., Dubal S. Schizotypy, depression, and anxiety in physical and social anhedonia. J. Clin. Psychol. 2009, 65(7):695-708.
29. Riecher-Rössler A., Pflueger M.O., Aston J., Borgwardt S.J., Brewer W.J., Gschwandtner U., Stieglitz R.D. Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up. Biol. Psychiatry 2009, 66(11):1023-1030.
30. Rietdijk J., Dragt S., Klaassen R., Ising H., Nieman D., Wunderink L., Delespaul P., Cuijpers P., Linszen D., van der Gaag M. A single blind randomized controlled trial of cognitive behavioural therapy in a help-seeking population with an At Risk Mental State for psychosis: the Dutch Early Detection and Intervention Evaluation (EDIE-NL) trial. Trials 2010, 22:11-30.
31. Ruhrmann S., Bodatsch M., Schultze-Lutter F., Salokangas R.K.R., Linszen D.H., Birchwood M., Juckel G., Lewis S., Klosterkötter J. Persistent negative symptoms and the risk for psychosis. Abstract ( Presented at the 7th international conference on early psychosis). Early Interv. Psychiatry 2010, 4(1):95.
32. Stefanis N.C., Hanssen M., Smirnis N.K., Avramopoulos D.A., Evdokimidis I.K., Stefanis C.N., Verdoux H., Van Os J. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol. Med. 2002, 32(2):347-358.
33. Velthorst E., Nieman D.H., Becker H.E., van der Fliert R., Dingemans P.M., Klaassen R., de Haan L., van Amelsvoort T., Linszen D.H. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophr. Res. 2009, 109(1-3):60-65.
34. Verdoux H., van Os J. Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr. Res. 2002, 54(102):59-65.
35. Verdoux H., Sorbara F., Gindre C., Swendsen J.D., van Os J. Cannabis use and dimensions of psychosis in a nonclinical population of female subjects. Schizophr. Res. 2003, 59(1):77-84.
36. Vollema M.G., Ormel J. The reliability of the structured interview for schizotypy-revised. Schizophr. Bull. 2000, 26(3):619-629.
37. Wechsler D. WAIS-III: Wechsler adult intelligence scale. Administration and Scoring Manual 1997, Psychological Corporation, San Antonio, TX, USA. 3rd edn.
38. Yung A.R., Buckby J.A., Cotton S.M., Cosgrave E.M., Killackey E.J., Stanford C., Godfrey K., McGorry P.D. Psychotic-like experiences in nonpsychotic Help-seekers: associations with distress, depression, and disability. Schizophr. Bull. 2006, 32(2):352-359.